SI1252155T1 - Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- (4r-(3s-hydroxy-1-methyl)piperidinyl)-4h-1-benzopyran-4-one - Google Patents
Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- (4r-(3s-hydroxy-1-methyl)piperidinyl)-4h-1-benzopyran-4-oneInfo
- Publication number
- SI1252155T1 SI1252155T1 SI200130293T SI200130293T SI1252155T1 SI 1252155 T1 SI1252155 T1 SI 1252155T1 SI 200130293 T SI200130293 T SI 200130293T SI 200130293 T SI200130293 T SI 200130293T SI 1252155 T1 SI1252155 T1 SI 1252155T1
- Authority
- SI
- Slovenia
- Prior art keywords
- benzopyran
- piperidinyl
- chlorophenyl
- dihydroxy
- cis
- Prior art date
Links
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 title 2
- 239000012453 solvate Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US48781500A | 2000-01-18 | 2000-01-18 | |
| PCT/US2001/000520 WO2001053294A1 (fr) | 2000-01-18 | 2001-01-08 | Solvate d'ethanol sous forme (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one |
| EP01902993A EP1252155B1 (fr) | 2000-01-18 | 2001-01-08 | Solvate d'ethanol sous forme (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1252155T1 true SI1252155T1 (en) | 2005-06-30 |
Family
ID=23937213
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200130293T SI1252155T1 (en) | 2000-01-18 | 2001-01-08 | Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- (4r-(3s-hydroxy-1-methyl)piperidinyl)-4h-1-benzopyran-4-one |
Country Status (26)
| Country | Link |
|---|---|
| EP (1) | EP1252155B1 (fr) |
| JP (1) | JP2003520798A (fr) |
| KR (1) | KR100825530B1 (fr) |
| CN (1) | CN1395577A (fr) |
| AR (1) | AR027226A1 (fr) |
| AT (1) | ATE284400T1 (fr) |
| AU (1) | AU2001230869A1 (fr) |
| BR (1) | BR0107724A (fr) |
| CA (1) | CA2397594C (fr) |
| CZ (1) | CZ301235B6 (fr) |
| DE (1) | DE60107652T2 (fr) |
| DK (1) | DK1252155T3 (fr) |
| EA (1) | EA005182B1 (fr) |
| ES (1) | ES2228800T3 (fr) |
| HU (1) | HU225155B1 (fr) |
| IL (2) | IL150643A0 (fr) |
| MX (1) | MXPA02006965A (fr) |
| NO (1) | NO322626B1 (fr) |
| NZ (1) | NZ520281A (fr) |
| PL (1) | PL201690B1 (fr) |
| PT (1) | PT1252155E (fr) |
| SI (1) | SI1252155T1 (fr) |
| SK (1) | SK287216B6 (fr) |
| TW (1) | TWI293072B (fr) |
| WO (1) | WO2001053294A1 (fr) |
| ZA (1) | ZA200205640B (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20190175598A1 (en) | 2016-08-23 | 2019-06-13 | Eisai R&D Management Co., Ltd. | Combination therapies for the treatment of hepatocellular carcinoma |
| US11083722B2 (en) | 2017-03-16 | 2021-08-10 | Eisai R&D Management Co., Ltd. | Combination therapies for the treatment of breast cancer |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IN164232B (fr) * | 1986-04-11 | 1989-02-04 | Hoechst India | |
| US5284856A (en) * | 1988-10-28 | 1994-02-08 | Hoechst Aktiengesellschaft | Oncogene-encoded kinases inhibition using 4-H-1-benzopyran-4-one derivatives |
| DE3836676A1 (de) * | 1988-10-28 | 1990-05-03 | Hoechst Ag | Die verwendung von 4h-1-benzopyran-4-on-derivaten, neue 4h-1-benzopyran-4-on-derivate und diese enthaltende arzneimittel |
| US5908934A (en) * | 1996-09-26 | 1999-06-01 | Bristol-Myers Squibb Company | Process for the preparation of chiral ketone intermediates useful for the preparation of flavopiridol and analogs |
-
2001
- 2001-01-08 AU AU2001230869A patent/AU2001230869A1/en not_active Abandoned
- 2001-01-08 CA CA2397594A patent/CA2397594C/fr not_active Expired - Fee Related
- 2001-01-08 CZ CZ20022467A patent/CZ301235B6/cs not_active IP Right Cessation
- 2001-01-08 SK SK1037-2002A patent/SK287216B6/sk not_active IP Right Cessation
- 2001-01-08 WO PCT/US2001/000520 patent/WO2001053294A1/fr not_active Ceased
- 2001-01-08 PT PT01902993T patent/PT1252155E/pt unknown
- 2001-01-08 ES ES01902993T patent/ES2228800T3/es not_active Expired - Lifetime
- 2001-01-08 DE DE60107652T patent/DE60107652T2/de not_active Expired - Lifetime
- 2001-01-08 BR BR0107724-4A patent/BR0107724A/pt not_active Application Discontinuation
- 2001-01-08 PL PL355992A patent/PL201690B1/pl not_active IP Right Cessation
- 2001-01-08 MX MXPA02006965A patent/MXPA02006965A/es active IP Right Grant
- 2001-01-08 JP JP2001553768A patent/JP2003520798A/ja active Pending
- 2001-01-08 KR KR1020027009140A patent/KR100825530B1/ko not_active Expired - Fee Related
- 2001-01-08 HU HU0204297A patent/HU225155B1/hu not_active IP Right Cessation
- 2001-01-08 SI SI200130293T patent/SI1252155T1/xx unknown
- 2001-01-08 CN CN01803857A patent/CN1395577A/zh active Pending
- 2001-01-08 NZ NZ520281A patent/NZ520281A/en not_active IP Right Cessation
- 2001-01-08 IL IL15064301A patent/IL150643A0/xx unknown
- 2001-01-08 AT AT01902993T patent/ATE284400T1/de active
- 2001-01-08 DK DK01902993T patent/DK1252155T3/da active
- 2001-01-08 EA EA200200776A patent/EA005182B1/ru not_active IP Right Cessation
- 2001-01-08 EP EP01902993A patent/EP1252155B1/fr not_active Expired - Lifetime
- 2001-01-17 AR ARP010100186A patent/AR027226A1/es not_active Application Discontinuation
- 2001-01-17 TW TW090101052A patent/TWI293072B/zh not_active IP Right Cessation
-
2002
- 2002-07-08 IL IL150643A patent/IL150643A/en not_active IP Right Cessation
- 2002-07-12 NO NO20023385A patent/NO322626B1/no not_active IP Right Cessation
- 2002-07-15 ZA ZA200205640A patent/ZA200205640B/en unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUS1300057I1 (hu) | Új fenil-propargil-éter-származékok | |
| AU143493S (en) | Tubular package for door hardware | |
| AR028343A1 (es) | Derivados de pirrolidina y piperidina | |
| AR028596A1 (es) | Nuevos derivados de fenilglicina | |
| IL154343A0 (en) | Phenoxybenzylamine derivatives as selective serotonin re-uptake inhibitors | |
| HUP0202578A3 (en) | Novel derivatives of flavones, xanthones and coumarins | |
| IL152893A0 (en) | Novel benzofuran derivatives | |
| IL154240A0 (en) | 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods | |
| SI1252155T1 (en) | Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8- (4r-(3s-hydroxy-1-methyl)piperidinyl)-4h-1-benzopyran-4-one | |
| AU2001271018A1 (en) | Gpr14 antagonist | |
| AU2001271280A1 (en) | Preparation of 4-hydroxy-3(2h)-furanones | |
| AU4834001A (en) | Method for producing benzo annelated heterocycles | |
| PT1440067E (pt) | Derivados n-formilo de paroxetina | |
| AUPQ825300A0 (en) | Method of sentence analysis | |
| ATE273303T1 (de) | Pseudopolymorph von (-)-cis-2-(2-chlorphenyl)-5,7-dihydroxy-8(4r-(3 -hydroxy-1-methyl)piperidinyl)- 4h-1-benzopyran-4-on hydrochlorid | |
| PL347407A1 (en) | Method of obtaining derivatives of 5,6,7,8-tetrahydronaphtalen-2-ole | |
| TW435780U (en) | Repetition pianissimo controller | |
| AU2001293825A1 (en) | Hollow block | |
| TW491048U (en) | Improved structure of bracket for keyboard | |
| HUP0301741A3 (en) | Method for producing 4-bromine-aniline derivatives | |
| PL339237A1 (en) | Method of obtaining anhydrous ethanol | |
| GB0009453D0 (en) | PT1B-Inhibiting phenanthrenyl derivatives | |
| SI1212312T1 (en) | Novel derivatives of flavones, xanthones and coumarins | |
| SI1280792T1 (en) | Method for producing benzo annelated heterocycles | |
| TW521610U (en) | Structure of moveable enclosed display closet |